Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 637

  • The following term was ignored: AND
  • See the search details.
1.

Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry.

Kluin-Nelemans HC, Reiter A, Illerhaus A, van Anrooij B, Hartmann K, Span LFR, Gorska A, Niedoszytko M, Lange M, Scaffidi L, Zanotti R, Bonadonna P, Perkins C, Elena C, Malcovati L, Shoumariyeh K, von Bubnoff N, Parente R, Triggiani M, Schwaab J, Jawhar M, Caroppo F, Fortina AB, Brockow K, Zink A, Fuchs D, Kilbertus A, Yavuz AS, Doubek M, Mattsson M, Hagglund H, Panse J, Sabato V, Aberer E, Niederwieser D, Breynaert C, Várkonyi J, Kennedy V, Lortholary O, Jakob T, Hermine O, Rossignol J, Arock M, Gotlib J, Valent P, Sperr WR.

Leukemia. 2019 Nov 18. doi: 10.1038/s41375-019-0632-4. [Epub ahead of print]

PMID:
31740811
2.

Levocetirizine for the Treatment of Itch in Psoriasis Patients: An Open-label Pilot Study in a Real-world Setting.

Mueller SM, Navarini AA, Goldust M, Brandt O, Griffiths CEM, Kleyn CE.

Dermatol Ther. 2019 Nov 12. doi: 10.1111/dth.13166. [Epub ahead of print]

PMID:
31714659
3.

International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study.

Sperr WR, Kundi M, Alvarez-Twose I, van Anrooij B, Oude Elberink JNG, Gorska A, Niedoszytko M, Gleixner KV, Hadzijusufovic E, Zanotti R, Bonadonna P, Bonifacio M, Perkins C, Illerhaus A, Elena C, Merante S, Shoumariyeh K, von Bubnoff N, Parente R, Jawhar M, Belloni Fortina A, Caroppo F, Brockow K, Zink A, Fuchs D, Kilbertus AJ, Yavuz AS, Doubek M, Hägglund H, Panse J, Sabato V, Bretterklieber A, Niederwieser D, Breynaert C, Hartmann K, Triggiani M, Nedoszytko B, Reiter A, Orfao A, Hermine O, Gotlib J, Arock M, Kluin-Nelemans HC, Valent P.

Lancet Haematol. 2019 Oct 29. pii: S2352-3026(19)30166-8. doi: 10.1016/S2352-3026(19)30166-8. [Epub ahead of print]

PMID:
31676322
4.

Syphilis Reactivates Latent Epstein-Barr Virus Reservoir via Toll-Like Receptor 2 and B-Cell Receptor Activation.

Hirsiger JR, Fuchs PS, Häusermann P, Müller-Durovic B, Daikeler T, Recher M, Hirsch HH, Terracciano L, Berger CT.

Open Forum Infect Dis. 2019 Jul 3;6(9):ofz317. doi: 10.1093/ofid/ofz317. eCollection 2019 Sep.

5.

Arginine- but not alanine-rich carboxy-termini trigger nuclear translocation of mutant keratin 10 in ichthyosis with confetti.

Renz P, Imahorn E, Spoerri I, Aushev M, March OP, Wariwoda H, Von Arb S, Volz A, Itin PH, Reichelt J, Burger B.

J Cell Mol Med. 2019 Dec;23(12):8442-8452. doi: 10.1111/jcmm.14727. Epub 2019 Oct 22.

6.

Observer-independent assessment of psoriasis affected area using machine learning.

Meienberger N, Anzengruber F, Amruthalingam L, Christen R, Koller T, Maul JT, Pouly M, Djamei V, Navarini AA.

J Eur Acad Dermatol Venereol. 2019 Oct 8. doi: 10.1111/jdv.16002. [Epub ahead of print]

PMID:
31594034
7.

Targeting tumor-resident mast cells for effective anti-melanoma immune responses.

Kaesler S, Wölbing F, Kempf WE, Skabytska Y, Köberle M, Volz T, Sinnberg T, Amaral T, Möckel S, Yazdi A, Metzler G, Schaller M, Hartmann K, Weide B, Garbe C, Rammensee HG, Röcken M, Biedermann T.

JCI Insight. 2019 Oct 3;4(19). pii: 125057. doi: 10.1172/jci.insight.125057.

8.

Acute Liver Failure in a Patient Treated With Metamizole.

Krisai P, Rudin D, Grünig D, Scherer K, Pichler W, Terracciano L, Krähenbühl S.

Front Pharmacol. 2019 Sep 11;10:996. doi: 10.3389/fphar.2019.00996. eCollection 2019.

9.

Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry.

Cazzaniga S, Anzengruber F, Augustin M, Boehncke WH, Borradori L, Conrad C, Cozzio A, Djamei V, French LE, Gilliet M, Häusermann P, Heidemeyer K, Itin P, Kolios AGA, Laffitte E, Maul JT, Mainetti C, Naldi L, Navarini AA, Rustenbach SJ, Simon D, Sorbe C, Streit M, Yawalkar N.

J Eur Acad Dermatol Venereol. 2019 Sep 28. doi: 10.1111/jdv.15983. [Epub ahead of print]

PMID:
31562785
10.

Smart identification of psoriasis by images using convolutional neural networks: a case study in China.

Zhao S, Xie B, Li Y, Zhao X, Kuang Y, Su J, He X, Wu X, Fan W, Huang K, Su J, Peng Y, Navarini AA, Huang W, Chen X.

J Eur Acad Dermatol Venereol. 2019 Sep 21. doi: 10.1111/jdv.15965. [Epub ahead of print]

PMID:
31541556
11.

Management of allergy transfer upon solid organ transplantation.

Muller YD, Vionnet J, Beyeler F, Eigenmann P, Caubet JC, Villard J, Berney T, Scherer K, Spertini F, Fricker MP, Lang C, Schmid-Grendelmeier P, Benden C, Roux Lombard P, Aubert V, Immer F, Pascual M, Harr T; Swiss Transplant Cohort Study.

Am J Transplant. 2019 Sep 18. doi: 10.1111/ajt.15601. [Epub ahead of print]

PMID:
31535461
12.

SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1-Nrf2.

Burgener AV, Bantug GR, Meyer BJ, Higgins R, Ghosh A, Bignucolo O, Ma EH, Loeliger J, Unterstab G, Geigges M, Steiner R, Enamorado M, Ivanek R, Hunziker D, Schmidt A, Müller-Durovic B, Grählert J, Epple R, Dimeloe S, Lötscher J, Sauder U, Ebnöther M, Burger B, Heijnen I, Martínez-Cano S, Cantoni N, Brücker R, Kahlert CR, Sancho D, Jones RG, Navarini A, Recher M, Hess C.

Nat Immunol. 2019 Oct;20(10):1311-1321. doi: 10.1038/s41590-019-0482-2. Epub 2019 Sep 16.

PMID:
31527833
13.
14.

[Rosacea - manifestations and treatment options].

Lohbeck A, Anzengruber F, Navarini AA.

Ther Umsch. 2019 Aug;76(2):84-91. doi: 10.1024/0040-5930/a001067. German.

PMID:
31429390
15.

Dermatologie für den Allgemeinpraktiker – Dermatology for General Physicians.

Itin P.

Ther Umsch. 2019 Aug;76(2):53-54. doi: 10.1024/0040-5930/a001061. German. No abstract available.

PMID:
31429389
16.

Assessment of the impact of sex in intensity, skin flares and central processing of histaminergic itch-A pilot study.

Mueller SM, Mueller F, Reinhardt J, Itin P, Navarini A, Stippich C, Borgwardt S.

Exp Dermatol. 2019 Aug 16. doi: 10.1111/exd.14021. [Epub ahead of print]

PMID:
31419309
17.

Effectiveness of methotrexate in moderate to severe psoriasis patients: real-world registry data from the Swiss Dermatology Network for Targeted Therapies (SDNTT).

Drach M, Papageorgiou K, Maul JT, Djamei V, Yawalkar N, Häusermann P, Anzengruber F, Navarini AA.

Arch Dermatol Res. 2019 Dec;311(10):753-760. doi: 10.1007/s00403-019-01945-6. Epub 2019 Aug 8.

PMID:
31396693
18.

Assessment of the risk and characterization of non-melanoma skin cancer in Kindler syndrome: study of a series of 91 patients.

Guerrero-Aspizua S, Conti CJ, Escamez MJ, Castiglia D, Zambruno G, Youssefian L, Vahidnezhad H, Requena L, Itin P, Tadini G, Yordanova I, Martin L, Uitto J, Has C, Del Rio M.

Orphanet J Rare Dis. 2019 Jul 24;14(1):183. doi: 10.1186/s13023-019-1158-6.

19.

Sex differences in the pharmacology of itch therapies-a narrative review.

Schmid Y, Navarini A, Thomas ZM, Pfleiderer B, Krähenbühl S, Mueller SM.

Curr Opin Pharmacol. 2019 Jun;46:122-142. doi: 10.1016/j.coph.2019.05.008. Epub 2019 Jul 9. Review.

PMID:
31299512
20.

Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.

Valent P, Bonadonna P, Hartmann K, Broesby-Olsen S, Brockow K, Butterfield JH, Triggiani M, Lyons JJ, Oude Elberink JNG, Arock M, Metcalfe DD, Akin C.

Int Arch Allergy Immunol. 2019;180(1):44-51. doi: 10.1159/000501079. Epub 2019 Jun 28. Review.

Supplemental Content

Loading ...
Support Center